Latest data shows the largest indicative borrow rate increases among liquid option names include: Humacyte (HUMA) 20.80% +5.81, Ginkgo Bioworks (DNA) 15.38% +0.91, Endeavour Silver (EXK) 1.20% +0.69, Poet Technologies (POET) 33.16% +0.62, Crispr Therapeutics (CRSP) 5.40% +0.58, ProShares UltraShort S&P 500 (SDS) 4.42% +0.52, Luminar Technologies (LAZR) 77.60% +0.40, Microvast Holdings (MVST) 6.29% +0.40, FingerMotion (FNGR) 12.04% +0.36, and Virgin Galactic (SPCE) 43.84% +0.32.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUMA:
- Humacyte’s Earnings Call: Balancing Achievements and Challenges
- Humacyte Stock (HUMA) Hits Record Low Post Q4 Results Despite FDA Nod for Vascular Trauma Treatment
- Humacyte’s Symvess Gains FDA Approval and Launches
- Lululemon reports Q4 beat, CoreWeave IPO priced at $40: Morning Buzz
- Biotech Alert: Searches spiking for these stocks today